Skip to main content
Fig. 3 | Porcine Health Management

Fig. 3

From: Safety and long-lasting immunity of the combined administration of a modified-live virus vaccine against porcine reproductive and respiratory syndrome virus 1 and an inactivated vaccine against porcine parvovirus and Erysipelothrix rhusiopathiae in breeding pigs

Fig. 3

Comparison among groups of PRRSV-specific cell-mediated immune responses (IFN-γ ELISPOT) for a given strain. Peripheral blood mononuclear cells (PBMC) were stimulated with either of the PRRSV strains: Fig. 3a (PRRSV1 3262); Fig. 3b (PRRSV1 3267), Fig. 3c (MLV PRRSV1) and Fig. 3d (PRRSV2 VR-2332). In all figures, solid black line corresponds to vaccinated animals: (↑) vaccinated with the combined administration of a PRRSV MLV vaccine and an inactivated PPV and Erysipelothrix rhusiopathiae vaccine at days 0, 21 and 147 of the experiment. Dotted grey line correspond to controls. Results are shown as average frequencies of virus-specific IFN-γ secreting cells per million of PBMC. Different superscript letters (a,b) indicate statistically significant differences between groups (Kruskal-Wallis test; p < 0.05). n.s. = non-significant. * Statistically significant differences within a strain between a given sample and the previous one (Friedman test; p < 0.05)

Back to article page